New Jersey 11th District

New Jersey's 11th congressional district, anchored in Morris County's affluent suburbs and stretching into Essex and Passaic, has drifted steadily toward Democrats over the past decade as college-educated voters realigned away from the national Republican Party. Cook Political Report rated the seat Solid D as of August 25, 2026, and the baseline electoral margin sits roughly 10 points in Democrats' favor. A March 2026 poll showed the Democratic candidate leading by 17 points, a margin consistent with the district's recent trajectory rather than an outlier. The district's economic profile complicates any simple populist reading. Morris County hosts the northeastern operations of several major pharmaceutical manufacturers, including facilities tied to companies whose drug-pricing practices have drawn bipartisan congressional scrutiny. Voters here are simultaneously among the wealthiest in New Jersey and among the most exposed to insurance-industry consolidation in the state's health corridor. The Democratic incumbent's positioning on pharmaceutical pricing and financial-sector regulation carries real weight in a district where both the donor class and the professional workforce live within the same zip codes. With no credible Republican challenger having emerged and both raters placing the seat well outside competitive range, the November outcome is not in serious doubt. What the district will test instead is whether a safe Democratic seat in a high-income suburb produces a member willing to press on drug-pricing transparency or hospital-merger review, or one whose fundraising relationships with the pharmaceutical corridor counsel a quieter approach. That internal accountability question, invisible in the topline ratings, is where the district's actual leverage over concentrated economic power sits.